Tirzepatide Tablets
(Oral GLP‑1)
One of the strongest weight‑loss momentum for many adults—dual‑action GLP‑1/GIP with a simple, once‑weekly routine.
What it is
Tirzepatide (brand names Mounjaro and Zepbound) offers significant health benefits primarily in managing type 2 diabetes and promoting substantial weight loss. Its dual-action mechanism as a GIP and GLP-1 receptor agonist also contributes to several related cardiometabolic improvements.
What it is
Adults who want a potent weekly option and a straightforward plan.
The statements on this page have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The FDA does not review or approve any compounded medications for safety or effectiveness. Off-label use must be prescribed and supervised by a licensed provider.
Why customers choose Tirzepatide
Zero needles
Same GLP‑1 class—simplified daily routine.
Cravings dialed down
Earlier fullness, fewer snack impulses, easier “no thanks.”*
Weekly rhythm, done right
Clinician‑guided titration and portal check‑ins keep it smooth.
Cash‑pay, no surprises
Clear pricing and refill control
Primary Benefits
Significant Weight Loss:
In clinical trials, adults with obesity using tirzepatide lost an average of 15% to over 20% of their initial body weight over 72 weeks, significantly more than with diet and exercise alone or other medications like semaglutide. This is primarily driven by reduced appetite, slowed gastric emptying, and enhanced metabolism.
Improved Glycemic Control
Tirzepatide is FDA-approved for managing type 2 diabetes and has been shown to lower HbA1c levels (a measure of long-term blood sugar) more effectively than other diabetes medications, including insulin and semaglutide.
Treatment of Obstructive Sleep Apnea (OSA)
Tirzepatide (Zepbound brand) is also FDA-approved for treating moderate to severe OSA in adults with obesity, by lowering the number of breathing disruptions during sleep and reducing body weight.
- How It Works
- How It Works
- How It Works
- How It Works
- How It Works
Quick medical questionnaire.
Clinician reviews asynchronously and messages your plan.
If approved, U.S. pharmacy ships; manage dose/refills in your portal.
Additional Health Improvements
Cardiovascular Health
Tirzepatide has shown promising results in reducing cardiovascular risk factors. Studies indicate it can lower blood pressure and cholesterol levels, and research from the SUMMIT trial shows it reduces the risk of cardiovascular death or worsening heart failure in patients with obesity and a specific type of heart failure (HFpEF).
Improved Lipid Profile
It helps improve cholesterol profiles by reducing total cholesterol, LDL ("bad") cholesterol, and triglycerides, while increasing HDL ("good") cholesterol levels
Reduced Inflammation
The medication has demonstrated anti-inflammatory properties, lowering key inflammatory markers associated with chronic diseases, which may contribute to its broad metabolic benefits.
Better Metabolic Health and Body Composition
Beyond weight on the scale, tirzepatide reduces visceral fat (dangerous belly fat around organs) and can improve insulin sensitivity, helping the body process sugar more efficiently.
Potential for Other Conditions
Ongoing research is exploring its use in treating other conditions linked to obesity and inflammation, such as metabolic dysfunction-associated steatohepatitis (MASH, a type of fatty liver disease), polycystic ovary syndrome (PCOS), and even certain neuroprotective effects.
Compare vs Competitors
| Name | Details |
|---|---|
| RO Body | $45 first month, then $145/mo membership; medication cost not included (cash‑pay GLP‑1s start $349/mo) |
| Hims | GLP‑1 plans advertised from $199/mo with 6‑month prepay; non‑GLP‑1 oral kits from $69/mo (10‑month prepay). |
| Friday | “One transparent monthly price” with coaching included (site lists all‑in monthly pricing structure). |
| Eden | GLP‑1s advertised “$139 first month, then $239/mo” on select plans. |
| Rugiet | Promotes non‑GLP‑1 oral combos for weight vs. GLP‑1 injections. (Membership options from $99/mo noted in support article.) |
You have questions ? Get answers
Positive, Proof‑backed
*Results vary; your plan is individualized.
Disclaimer: Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. The FDA does not review or approve any compounded medications for safety or effectiveness. These treatments are individualized and do not guarantee specific results. Provider-determined, off-label use may apply.